Related content

Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 10, 2016-08 ,pp. : 1325-1338

Bentham Science Publishers

Access to resources Recommend Favorite

Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells

By Hu Min   Liu Qingsong   Song Peipei   Zhan Xiaoqin   Luo Min   Liu Chen   Yang Dandan   Cai Yan   Zhang Fan   Jiang Fengbing   Zhang Yan   Tang Min   Zuo Guowei   Zhou Lan   Luo Jinyong   Shi Qiong   Weng Yaguang  

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 185-192

Spandidos Publications

Access to resources Recommend Favorite

The Solid State, Solution and Tubulin-Bound Conformations of Agents that Promote Microtubule Stabilization

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 1, 2018-06 ,pp. : 91-122

Bentham Science Publishers

Access to resources Recommend Favorite

Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 1, 2013-01 ,pp. : 147-158

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib

By                  

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 734-740

Spandidos Publications

Access to resources Recommend Favorite